These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessing health-related quality of life in gynecologic oncology. Nordin AJ; Greimel E; Int J Gynecol Cancer; 2010 Nov; 20(8):1301. PubMed ID: 21051967 [No Abstract] [Full Text] [Related]
6. Complementary and alternative therapy use in gynecologic oncology: implications for clinical practice. Richardson MA Gynecol Oncol; 2002 Mar; 84(3):360-2. PubMed ID: 11855869 [No Abstract] [Full Text] [Related]
7. Highlights from the Society of Gynecologic Oncology 2017 Annual Meeting on Women's Cancer. Cantrell LA; Backes F Gynecol Oncol; 2017 Jun; 145(3):483-485. PubMed ID: 28456377 [No Abstract] [Full Text] [Related]
8. Bibliography. Current world literature. Gynecologic oncology and pathology. Curr Opin Obstet Gynecol; 1999 Feb; 11(1):87-112. PubMed ID: 10047970 [No Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track. Tewari KS Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779 [TBL] [Abstract][Full Text] [Related]
10. What constitutes the "optimal" treatment environment of women with gynecologic cancer? Orr JW Gynecol Oncol; 2003 Apr; 89(1):1-3. PubMed ID: 12694646 [No Abstract] [Full Text] [Related]
11. Gynecologic oncology as a specialty. Current status. Bõsze P Eur J Gynaecol Oncol; 1996; 17(2):91-5. PubMed ID: 8654475 [No Abstract] [Full Text] [Related]
12. Joint ENGOT and GOG Foundation requirements for trials with industry partners. Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez Martin A; Copeland LJ; Int J Gynecol Cancer; 2019 Sep; 29(7):1094-1097. PubMed ID: 31320391 [No Abstract] [Full Text] [Related]
14. Expanding the pipeline. The 2018 Society of Gynecologic Oncology presidential address. Rice LW Gynecol Oncol; 2018 Jun; 149(3):435-438. PubMed ID: 29729931 [No Abstract] [Full Text] [Related]
15. The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. Aviki EM; Schleicher SM; Boyd L; Liang M; Ko EM; Zanotti K; Moss H Gynecol Oncol; 2021 Sep; 162(3):529-531. PubMed ID: 34294415 [No Abstract] [Full Text] [Related]
17. The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation. Monk BJ; Coleman RL; Herzog TJ; Moore KN; O'Malley DM; Randall LM; Slomovitz BM; Eskander R; Pothuri B; Reese LL; Mannel RS; Copeland LJ Gynecol Oncol; 2021 Jul; 162(1):203-209. PubMed ID: 33722417 [TBL] [Abstract][Full Text] [Related]
18. Report on NRG Oncology and the GOG Foundation. Alvarez RD Gynecol Oncol; 2015 Oct; 139(1):3-4. PubMed ID: 26325528 [No Abstract] [Full Text] [Related]
19. Gynaecological oncology. Gore M Curr Opin Oncol; 2008 Sep; 20(5):547. PubMed ID: 19106658 [No Abstract] [Full Text] [Related]
20. Clinical Centers of Excellence. Gynecologic oncology. Duke University Medical Center. Aungst H Med Econ; 2009 Feb; 86(4):24. PubMed ID: 19405372 [No Abstract] [Full Text] [Related] [Next] [New Search]